Loading...
Medicube Hyaluronic Multi Peptide PDRN Serum scores 9.0/9.8 vs Paula's Choice Calm Redness Relief Moisturizer at 8.1/9.8. Medicube Hyaluronic Multi Peptide PDRN Serum wins for active ingredients.
Medicube Hyaluronic Multi Peptide PDRN Serum edges ahead, winning 1 of 5 attributes.
Scores last verified: April 2026
35 unique
32 unique
Where Medicube Hyaluronic Multi Peptide PDRN Serum really shines is active ingredient strength, scoring 7.5 compared to Paula's Choice Calm Redness Relief Moisturizer's 3.0. Its formula features Niacinamide, Allantoin, and Adenosine in high positions, signalling meaningful concentrations.
Medicube Hyaluronic Multi Peptide PDRN Serum brings Niacinamide, Allantoin, and Adenosine as actives, while paula's Choice Calm Redness Relief Moisturizer relies on Ceramide Np, Tocopherol, and Avena Sativa (Oat) Kernel Extract. Both approaches have merit, but the positioning and supporting ingredients make the difference.
Medicube Hyaluronic Multi Peptide PDRN Serum is better if you have
Paula's Choice Calm Redness Relief Moisturizer is better if you have
Paula's Choice Calm Redness Relief Moisturizer comes in at mid-range pricing with a 8.1 score, which is solid value at that tier.
Medicube Hyaluronic Multi Peptide PDRN Serum edges ahead with a slightly stronger formulation, but Paula's Choice Calm Redness Relief Moisturizer is still a solid pick.
Based on ingredient analysis, Medicube Hyaluronic Multi Peptide PDRN Serum scores higher overall. See the full score breakdown above for details on each attribute.
Yes, they share common ingredients. Check the ingredient face-off section above for a detailed comparison.
The key differences are in their active ingredients and formulation approach. Check the attribute battle above for a detailed breakdown.
Some links on this site are affiliate links. We may earn a commission from purchases made through our links, at no extra cost to you. This helps us keep Gracie free and independent.
© 2026 Gracie. All rights reserved. Data sourced from Open Beauty Facts (ODbL) and EU CosIng.